-
Trading ideas: 4 stocks recommendations for November 03
Centrum India is bullish on Glenmark with a price target of Rs 535 per share.
-
Glenmark partners with SaNOtize for Covid-19 nasal spray
SaNOtize developed and patented a Nitric Oxide Releasing Solution platform technology (NORSTM) to treat and prevent microbial infections in 2017.
-
New nasal spray launched for treatment of moderate to severe allergic rhinitis
This will provide patients a far more convenient, cost-effective treatment option in the country, Glenmark said in a regulatory filing.
-
New spray for children suffering from nasal itching, watery eyes gets Russian health ministry nod
Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis in adults and children over 12 years of age
-
Glenmark Pharma gains after USFDA approves
Glenmark Pharmaceuticals rose 1.85% to Rs 496.35 after the company said it received final approval from the US drug regulator for topiramate extended-
